Dynamics of SARS-CoV-2 lineages in French Guiana in 2020-2021: 4 epidemic waves with cross-influences from Europe and South America.

Dynamics of circulation French Guiana Genomic surveillance SARS-CoV2 variants Variant of concern

Journal

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
ISSN: 1567-7257
Titre abrégé: Infect Genet Evol
Pays: Netherlands
ID NLM: 101084138

Informations de publication

Date de publication:
11 2022
Historique:
received: 24 07 2022
revised: 24 09 2022
accepted: 26 09 2022
medline: 23 10 2023
pubmed: 3 10 2022
entrez: 2 10 2022
Statut: ppublish

Résumé

Since the first cases of SARS-CoV-2 infection in Wuhan in December 2019, this RNA virus gave rise to different viral lineages with different virological, epidemiological and immunological properties. Here we describe the dynamics of circulation of SARS-CoV-2 lineages in an Amazonian South American French overseas territory, French Guiana (FG). The data analyzed are based on the general epidemic course, and genomic surveillance data come from whole genome sequencing (WGS) as well as typing PCRs. From March 2020 to October 2021, four COVID-19 epidemic waves were observed in FG with an evolution of viral lineages influenced by virus introductions from continental France and above all by land-based introductions from neighbouring countries. The third epidemic wave from March to June 2021 was driven by a predominant Gamma introduced from Brazil and a less frequent Alpha introduced from France. This coexistence was completely substituted by Delta that initiated the fourth epidemic wave.

Identifiants

pubmed: 36184049
pii: S1567-1348(22)00167-8
doi: 10.1016/j.meegid.2022.105370
pmc: PMC9529336
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105370

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Alexandra Miliu (A)

Santé publique France, Regional unit French Guiana, Cayenne, French Guiana. Electronic address: guyane@santepubliquefrance.fr.

Anne Lavergne (A)

National Reference Center for Respiratory Viruses, Institut Pasteur de la Guyane, Cayenne, French Guiana.

Tiphanie Succo (T)

Santé publique France, Regional unit French Guiana, Cayenne, French Guiana.

Claire Laizé (C)

Agence régionale de santé (ARS) Guyane, Cayenne, French Guiana.

Audrey Andrieu (A)

Santé publique France, Regional unit French Guiana, Cayenne, French Guiana.

Antoine Enfissi (A)

National Reference Center for Respiratory Viruses, Institut Pasteur de la Guyane, Cayenne, French Guiana.

Vincent Enouf (V)

National Reference Center for Respiratory Viruses, Institut Pasteur, Paris, France.

Sylvie Van der Werf (S)

National Reference Center for Respiratory Viruses, Institut Pasteur, Paris, France. Electronic address: sylvie.van-der-werf@pasteur.fr.

Denis Blanchet (D)

Clinical Laboratory, Centre Hospitalier de Cayenne (CHC), Cayenne, French Guiana.

Magalie Demar (M)

Clinical Laboratory, Centre Hospitalier de Cayenne (CHC), Cayenne, French Guiana. Electronic address: magalie.demar@ch-cayenne.fr.

Jean-François Carod (JF)

Clinical laboratory of Centre Hospitalier de l'Ouest Guyanais (CHOG), Saint Laurent du Maroni, French Guiana. Electronic address: jf.carod@ch-ouestguyane.fr.

Thierry Carage (T)

Carage laboratory associated to Kourou hospital center (CHK), Kourou, French Guiana.

Claude Flamand (C)

National Reference Center for Respiratory Viruses, Institut Pasteur de la Guyane, Cayenne, French Guiana.

Sourakhata Tirera (S)

National Reference Center for Respiratory Viruses, Institut Pasteur de la Guyane, Cayenne, French Guiana.

Etienne Simon-Lorière (E)

Institut Pasteur, Université de Paris, G5 Evolutionary Genomics of RNA viruses, 75015 Paris, France. Electronic address: etienne.simon-loriere@pasteur.fr.

Cyril Rousseau (C)

Santé publique France, Regional unit French Guiana, Cayenne, French Guiana.

Dominique Rousset (D)

National Reference Center for Respiratory Viruses, Institut Pasteur de la Guyane, Cayenne, French Guiana. Electronic address: drousset@pasteur-cayenne.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH